In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Concentrix’s current price at $32.76 heavily undervalues its PERT-weighted fair value of $235.52, indicating substantial upside potential. However, poor financial health scores and high valuation volatility (104.28% coefficient of variation) highlight elevated operational and market risks. The 0% downside Monte Carlo risk below current price suggests limited near-term price erosion in modeled scenarios.